ATC Group: N05AL Benzamides

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of N05AL in the ATC hierarchy

Level Code Title
1 N Nervous system
2 N05 Psycholeptics
3 N05A Antipsychotics
4 N05AL Benzamides

Group N05AL contents

Code Title
N05AL01 Sulpiride
N05AL02 Sultopride
N05AL03 Tiapride
N05AL04 Remoxipride
N05AL05 Amisulpride
N05AL06 Veralipride
N05AL07 Levosulpiride

Active ingredients in N05AL

Active Ingredient Description
Amisulpride

Amisulpride is a neuroleptic. Amisulpride binds selectively with a high affinity to human dopaminergic D2/D3 receptor subtypes whereas it is devoid of affinity for D1, D4 and D5 receptor subtypes.

Levosulpiride

Levosulpiride is a selective antagonist at dopamine (D) receptors. Levosulpiride exerts a regulation action both on the central and peripheral nervous circuits controlling the dynamics of digestive system.

Nemonapride
Sulpiride

Sulpiride is a member of the group of substituted benzamides, which are structurally distinct from the phenothiazines, butyrophenones and thioxanthenes. One of the characteristics of sulpiride is its bimodal activity, as it has both antidepressant and neuroleptic properties. Schizophrenia characterised by a lack of social contact can benefit strikingly.

Sultopride
Tiapride

Tiapride is an atypical neuroleptic which exhibits selectivity in in-vitro studies for D2 and D3 dopamine subtype receptors without any affinity for subtype receptors of the principal central neurotransmitters (including serotonin, noradrenaline and histamine).

Related product monographs

Title Information Source Document Type  
DEVODIL Tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
DISLEP Solution for injection / infusion Medicines Authority (MT) MPI, EU: SmPC
ESPIRIDE Capsule Health Products Regulatory Authority (ZA) MPI, Generic
SOLIAN Tablets Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
SULPIREN Tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
SULVORID Tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC